U.S. Health Aid to African Countries Tied to Harmful Conditions - HRW

A recent report by Human Rights Watch (HRW) has exposed a new generation of U.S. bilateral health aid agreements with African countries, including Ethiopia, that tie vital assistance to concerning conditions. These pacts, negotiated under the U.S. "America First Global Health Strategy" following significant cuts to prior aid, reportedly mandate extensive abortion surveillance, broad access to health data, and extractive rights to pathogen samples for pharmaceutical development. HRW argues that these conditions undermine national sovereignty, jeopardize privacy rights, and could lead to more restrictive health policies, potentially violating international human rights standards. The report calls for immediate transparency and a re-evaluation of these agreements, which were often not publicly disclosed.

A recent Human Rights Watch (HRW) report, "US: Global Health Aid Tied to Harmful Conditions," released on June 8, 2026, has cast a critical spotlight on the United States' new approach to health assistance in Africa. The report details how bilateral health agreements, signed with at least seven African nations including Ethiopia, Kenya, Mozambique, Nigeria, Rwanda, Liberia, and Uganda, impose stringent and potentially detrimental conditions on recipient countries. These conditions reportedly include extensive surveillance mechanisms to ensure compliance with U.S. abortion restrictions, broad access to sensitive health data, and rights to biological specimen sharing for pharmaceutical development.

This development raises profound legal and ethical questions regarding national sovereignty, data privacy, reproductive rights, and equitable global health partnerships. For legal professionals advising governments, non-governmental organizations, and healthcare providers in affected regions, understanding the implications of these agreements is paramount. The article will delve into the legal framework underpinning these conditions, analyze their potential impact on human rights and public health systems, and explore the broader context of international health law and state sovereignty, particularly within the Ethiopian legal landscape.

The current U.S. approach to foreign health assistance stems from a significant policy shift. In early 2025, the U.S. government abruptly shut down the U.S. Agency for International Development (USAID), leading to an immediate cessation of health care supply chains and the closure of health programs globally. This drastic measure resulted in over $800 million in health aid cuts to several African countries, precipitating a public health crisis and threatening decades of progress, particularly in HIV/AIDS prevention and treatment. Subsequently, in September 2025, the U.S. Department of State launched its "America First Global Health Strategy," which replaced the previous aid model with direct bilateral agreements emphasizing conditionality and co-investment, ostensibly to reduce dependency on foreign assistance.

Central to the conditions imposed in these new agreements are long-standing U.S. legislative restrictions. The Helms Amendment, enacted in 1973 as an amendment to the Foreign Assistance Act of 1961, prohibits the use of U.S. foreign assistance funds "to pay for the performance of abortion as a method of family planning or to motivate or coerce any person to practice abortions." While its original intent was narrower, the Helms Amendment has been consistently interpreted by successive U.S. administrations as an outright ban on funding for abortion services under virtually all circumstances, including cases of rape, incest, or to save the life of the pregnant person. Furthermore, the Trump administration reinstated and significantly expanded the Mexico City Policy (also known as the Global Gag Rule) in January 2025, now termed the "Protecting Life in Foreign Assistance" policy. This policy applies to most non-military foreign assistance and prohibits recipient organizations from performing or actively promoting abortion as a method of family planning, and also extends to activities related to diversity, equity, and inclusion (DEI) and gender-affirming care.

Internationally, the framework for global health information sharing is largely governed by the International Health Regulations (IHR) (2005), a legally binding instrument adopted by 196 countries, including all WHO Member States. The IHR aims to prevent, protect against, control, and provide a public health response to the international spread of disease, while explicitly including safeguards to protect individual rights concerning personal data, informed consent, and non-discrimination in the application of health measures.

The HRW report highlights several "troubling conditions" embedded within the new bilateral health agreements. Firstly, the agreements reportedly require recipient countries to grant the U.S. government broad access to surveillance data and information to monitor compliance with the Helms Amendment. This includes provisions for unannounced inspections of health facilities in some countries, such as Uganda. HRW argues that this extensive surveillance, often without adequate privacy safeguards, could encourage a more restrictive regulation of abortion than national laws might otherwise mandate, thereby infringing upon the right to health care.

Secondly, the agreements with several countries, including Ethiopia, Rwanda, Uganda, Nigeria, and Mozambique, mandate "specimen sharing arrangements." These require recipient nations to provide the U.S. with biological samples, sequencing data, and other associated data related to novel and emerging infectious diseases with epidemic potential, as a condition for continued health funding. Critically, the terms of these arrangements have not been made public, and a leaked draft template suggests no guarantee of equitable access for the source countries to diagnostics, vaccines, or treatments developed from their own biological resources. This raises concerns about the potential for exploitation and undermines ongoing World Health Organization (WHO) negotiations aimed at establishing a more equitable pathogen access and benefit-sharing system.

Furthermore, the agreements raise serious concerns about the use of people's private health data. HRW notes that the pacts grant Washington broad access to health surveillance information without clear limits, uniform safeguards, or meaningful protections for patient confidentiality. There is no explicit prohibition on this data being shared with U.S. pharmaceutical companies without patient consent. This is particularly problematic in countries with nascent or evolving data protection frameworks. For instance, while Ethiopia enacted the Personal Data Protection Proclamation No. 1321/2024, which classifies health data as sensitive and requires prior approval for cross-border transfers, the broad demands for data access in these U.S. agreements could conflict with such domestic legal protections.

The context of these agreements also points to a significant power imbalance. The U.S. government's abrupt withdrawal of substantial health aid in early 2025 left many African nations in a precarious position, creating a coercive environment where governments are pressured to accept "troubling conditions" to restore vital assistance. This approach, coupled with reports of the U.S. linking health packages to access to natural resources (as seen with Zambia), suggests that health aid is being leveraged for broader strategic and economic interests, potentially at the expense of recipient countries' health sovereignty. The lack of transparency, with many agreements either briefly posted and then removed from public view or only available through leaks, further exacerbates these concerns, hindering public and legal scrutiny.

The Human Rights Watch report on U.S. health aid to African countries underscores a critical juncture in global health diplomacy. The conditional nature of these new bilateral agreements, particularly concerning abortion surveillance, broad data access, and specimen sharing, presents significant legal and ethical challenges for recipient nations. For legal practitioners, it is imperative to meticulously review these agreements, ensuring that they do not inadvertently compromise national data protection laws, undermine patient privacy, or infringe upon reproductive rights. The potential for these conditions to encourage more restrictive health policies than domestic laws dictate, coupled with the lack of equitable benefit-sharing mechanisms for biological resources, demands careful scrutiny and robust advocacy.

Moving forward, African governments and legal professionals must prioritize the assertion of health sovereignty and advocate for transparent, equitable, and rights-respecting partnerships. This includes pushing for the full public disclosure of all aid agreements, negotiating for clear data protection and benefit-sharing clauses, and ensuring that any surveillance mechanisms are proportionate and subject to independent oversight. The international community, including multilateral organizations like the WHO, must also reinforce frameworks that protect national autonomy and human rights in global health cooperation, ensuring that vital aid serves genuinely humanitarian goals without imposing harmful or extractive conditions.